Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05QNR
|
||||
Former ID |
DNC008436
|
||||
Drug Name |
N,N'-(1',9'-nonylene)-bis-(-)-nor-MEP
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529368] | ||
Structure |
Download2D MOL |
||||
Formula |
C37H58N2O2
|
||||
Canonical SMILES |
CCC1(CCCCN(C1)CCCCCCCCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4<br />=CC(=CC=C4)O
|
||||
InChI |
1S/C37H58N2O2/c1-3-36(32-18-16-20-34(40)28-32)22-10-14-26-38(30-36)24-12-8-6-5-7-9-13-25-39-27-15-11-23-37(4-2,31-39)33-19-17-21-35(41)29-33/h16-21,28-29,40-41H,3-15,22-27,30-31H2,1-2H3/t36-,37-/m1/s1
|
||||
InChIKey |
ZZKZUUMHRSWLQQ-FZNHDDJXSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [529368] | |
Acetylcholinesterase | Target Info | Inhibitor | [529368] | ||
KEGG Pathway | Glycerophospholipid metabolism | ||||
Cholinergic synapse | |||||
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
Pathway Interaction Database | ATF-2 transcription factor network | ||||
PathWhiz Pathway | Phospholipid Biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.